Abu Dhabi's sovereign wealth fund, Mubadala Investment Company, is planning to double its investment position in the Asian region over the next few years, a move that will utilize tens of billions of dollars in new investments. Currently, Mubadala has about $300 billion in assets under management, of which about 12 percent is invested in the Asian region. The firm hopes to increase that to nearly 25% by 2030.
While Mubadala currently dominates investments in Europe and the US, it is now turning its attention to emerging markets in Asia, particularly major economies such as China, India, Japan and South Korea. Mubadala still maintains a core focus on the US market, but has also shown a strong interest in Asian markets. In the life sciences and health sector in particular, the company has invested between $200 million and $500 million in the Asian market, and although this is lower than the amount it has invested in the North American and European markets (around $1 billion), the company says there is room for improvement.
The UAE has been increasingly inclined to cooperate and invest in projects with Asian countries such as China and India in recent years. the emergence of the UAE and Saudi Arabia as full members of BRICS in early 2023 has opened up new opportunities for UAE-based companies such as Mubadala to further collaborate with the Asian market.
Mubadala has entered the Chinese market before, in 2015, Mubadala, together with China's State Development Bank and the State Administration of Foreign Exchange, contributed $10 billion to invest in business projects in China, and now has more than 80 investment projects. In addition, Mubadala said there could be potential IPO opportunities in the future, particularly in terms of investments in the healthcare sector.
This adjustment to the investment program reflects Mubadala's positive approach to the Asian market and recognition of its long-term growth potential.